151 related articles for article (PubMed ID: 12133721)
1. Recent advances in the synthesis, design and selection of cysteine protease inhibitors.
Hernandez AA; Roush WR
Curr Opin Chem Biol; 2002 Aug; 6(4):459-65. PubMed ID: 12133721
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors.
Namoto K; Sirockin F; Sellner H; Wiesmann C; Villard F; Moreau RJ; Valeur E; Paulding SC; Schleeger S; Schipp K; Loup J; Andrews L; Swale R; Robinson M; Farady CJ
Bioorg Med Chem Lett; 2018 Mar; 28(5):906-909. PubMed ID: 29433930
[TBL] [Abstract][Full Text] [Related]
3. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
Wanga QM; Chen SH
Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
[TBL] [Abstract][Full Text] [Related]
4. Non-covalent inhibitors of rhinovirus 3C protease.
Baxter A; Chambers M; Edfeldt F; Edman K; Freeman A; Johansson C; King S; Morley A; Petersen J; Rawlins P; Spadola L; Thong B; Van de Poël H; Williams N
Bioorg Med Chem Lett; 2011 Jan; 21(2):777-80. PubMed ID: 21183345
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics.
Dragovich PS; Prins TJ; Zhou R; Johnson TO; Brown EL; Maldonado FC; Fuhrman SA; Zalman LS; Patick AK; Matthews DA; Hou X; Meador JW; Ferre RA; Worland ST
Bioorg Med Chem Lett; 2002 Mar; 12(5):733-8. PubMed ID: 11858991
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase synthesis of a combinatorial array of 1,3-bis(acylamino)-2-butanones, inhibitors of the cysteine proteases cathepsins K and L.
Yamashita DS; Dong X; Oh HJ; Brook CS; Tomaszek TA; Szewczuk L; Tew DG; Veber DF
J Comb Chem; 1999; 1(3):207-15. PubMed ID: 10746010
[TBL] [Abstract][Full Text] [Related]
7. Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease.
Kawatkar SP; Gagnon M; Hoesch V; Tiong-Yip C; Johnson K; Ek M; Nilsson E; Lister T; Olsson L; Patel J; Yu Q
Bioorg Med Chem Lett; 2016 Jul; 26(14):3248-3252. PubMed ID: 27265257
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors.
Im I; Lee ES; Choi SJ; Lee JY; Kim YC
Bioorg Med Chem Lett; 2009 Jul; 19(13):3632-6. PubMed ID: 19464175
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.
Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST
J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
[TBL] [Abstract][Full Text] [Related]
11. Structure-based combinatorial library design: discovery of non-peptidic inhibitors of caspases 3 and 8.
Head MS; Ryan MD; Lee D; Feng Y; Janson CA; Concha NO; Keller PM; deWolf WE
J Comput Aided Mol Des; 2001 Dec; 15(12):1105-17. PubMed ID: 12160093
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease.
Venkatraman S; Kong J; Nimkar S; Wang QM; Aubé J; Hanzlik RP
Bioorg Med Chem Lett; 1999 Feb; 9(4):577-80. PubMed ID: 10098667
[TBL] [Abstract][Full Text] [Related]
13. Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors.
Dragovich PS; Zhou R; Webber SE; Prins TJ; Kwok AK; Okano K; Fuhrman SA; Zalman LS; Maldonado FC; Brown EL; Meador JW; Patick AK; Ford CE; Brothers MA; Binford SL; Matthews DA; Ferre RA; Worland ST
Bioorg Med Chem Lett; 2000 Jan; 10(1):45-8. PubMed ID: 10636240
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a small library of diketopiperazines as potential inhibitors of calpain.
Zeng Y; Li Q; Hanzlik RP; Aubé J
Bioorg Med Chem Lett; 2005 Jun; 15(12):3034-8. PubMed ID: 15896956
[TBL] [Abstract][Full Text] [Related]
15. Total Synthesis of Covalent Cysteine Protease Inhibitor N-Desmethyl Thalassospiramide C and Crystallographic Evidence for Its Mode of Action.
Fournier J; Chen K; Mailyan AK; Jackson JJ; Buckman BO; Emayan K; Yuan S; Rajagopalan R; Misialek S; Adler M; Blaesse M; Griessner A; Zakarian A
Org Lett; 2019 Jan; 21(2):508-512. PubMed ID: 30628449
[TBL] [Abstract][Full Text] [Related]
16. A simple solid phase, peptide-based fluorescent assay for the efficient and universal screening of HRV 3C protease inhibitors.
Schünemann K; Connelly S; Kowalczyk R; Sperry J; Wilson IA; Fraser JD; Brimble MA
Bioorg Med Chem Lett; 2012 Aug; 22(15):5018-24. PubMed ID: 22763202
[TBL] [Abstract][Full Text] [Related]
17. Cysteine proteinase inhibitors as therapy for parasitic diseases: advances in inhibitor design.
Steverding D; Caffrey CR; Sajid M
Mini Rev Med Chem; 2006 Sep; 6(9):1025-32. PubMed ID: 17018001
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies.
Dragovich PS; Webber SE; Babine RE; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Reich SH; Prins TJ; Marakovits JT; Littlefield ES; Zhou R; Tikhe J; Ford CE; Wallace MB; Meador JW; Ferre RA; Brown EL; Binford SL; Harr JE; DeLisle DM; Worland ST
J Med Chem; 1998 Jul; 41(15):2806-18. PubMed ID: 9667970
[TBL] [Abstract][Full Text] [Related]
19. Solid-phase synthesis of azidomethylene inhibitors targeting cysteine proteases.
Yang PY; Wu H; Lee MY; Xu A; Srinivasan R; Yao SQ
Org Lett; 2008 May; 10(10):1881-4. PubMed ID: 18407644
[TBL] [Abstract][Full Text] [Related]
20. Solid-phase synthesis of cyclic alkoxyketones, inhibitors of the cysteine protease cathepsin K.
Fenwick AE; Garnier B; Gribble AD; Ife RJ; Rawlings AD; Witherington J
Bioorg Med Chem Lett; 2001 Jan; 11(2):195-8. PubMed ID: 11206457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
